Glenmede Trust CO Na Codexis, Inc. Transaction History

Glenmede Trust CO Na

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$9.8 - $12.77 $509 - $664	-52 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$13.12 - $17.06 $1,272 - $1,654	-97 Reduced 65.1%	52 $0
Q3 2019 Nov 14, 2019	SELL	$12.75 - $19.01 $20,718 - $30,891	-1,625 Reduced 91.6%	149 $2,000
Q1 2019 May 14, 2019	BUY	$15.53 - $22.15 $25,236 - $35,993	1,625 Added 1090.6%	1,774 $36,000
Q4 2018 Feb 14, 2019	BUY	$14.06 - $22.57 $2,094 - $3,362	149 New	149 $2,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $301M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.